-
1
-
-
0026636013
-
Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo
-
Alvarez Sotomayor E, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei III E: Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30:377-384, 1992
-
(1992)
Cancer Chemother Pharmacol
, vol.30
, pp. 377-384
-
-
Alvarez Sotomayor, E.1
Teicher, B.A.2
Schwartz, G.N.3
Holden, S.A.4
Menon, K.5
Herman, T.S.6
Frei III, E.7
-
2
-
-
0026486664
-
Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease
-
Teicher BA, Alvarez Sotomayor E, Huang ZD: Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702-6704, 1992
-
(1992)
Cancer Res
, vol.52
, pp. 6702-6704
-
-
Teicher, B.A.1
Alvarez Sotomayor, E.2
Huang, Z.D.3
-
3
-
-
0027143743
-
β-Cyclodextrin tetradecasulfate/tetrahydrocortisol ±minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma
-
Teicher BA, Alvarez Sotomayor E, Huang ZD, Ara G, Holden S, Khandekar V, Chen Y-N: β-Cyclodextrin tetradecasulfate/tetrahydrocortisol ±minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma. Cancer Chemother Pharmacol 33:229-238, 1993
-
(1993)
Cancer Chemother Pharmacol
, vol.33
, pp. 229-238
-
-
Teicher, B.A.1
Alvarez Sotomayor, E.2
Huang, Z.D.3
Ara, G.4
Holden, S.5
Khandekar, V.6
Chen, Y.-N.7
-
4
-
-
0028305809
-
Potentiation of cytotoxic cancer therapies by TNP-470 alone and with antiangiogenic agents
-
Teicher BA, Holden SA, Ara G, Alvarez Sotomayor E, Huang ZD, Chen Y-N, Brem H: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with antiangiogenic agents. Int J Cancer 57:920-925, 1994
-
(1994)
Int J Cancer
, vol.57
, pp. 920-925
-
-
Teicher, B.A.1
Holden, S.A.2
Ara, G.3
Alvarez Sotomayor, E.4
Huang, Z.D.5
Chen, Y.-N.6
Brem, H.7
-
5
-
-
0029147793
-
Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma
-
Teicher BA, Holden SA, Dupuis NP, Kakeji Y, Ikebe M, Emi Y, Goff D: Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Ca Res Trtmt 36:227-236, 1995
-
(1995)
Breast Ca Res Trtmt
, vol.36
, pp. 227-236
-
-
Teicher, B.A.1
Holden, S.A.2
Dupuis, N.P.3
Kakeji, Y.4
Ikebe, M.5
Emi, Y.6
Goff, D.7
-
6
-
-
0029120875
-
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma
-
Teicher BA, Dupuis NP, Robinson M, Emi Y, Goff D: Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma. Oncology Res 7(5):237-243, 1995
-
(1995)
Oncology Res
, vol.7
, Issue.5
, pp. 237-243
-
-
Teicher, B.A.1
Dupuis, N.P.2
Robinson, M.3
Emi, Y.4
Goff, D.5
-
7
-
-
84982729034
-
Antiangiogenic agents can increase tumor oxygenation and responses to radiation therapy
-
Teicher BA, Dupuis N, Kusomoto T, Robinson MF, Liu F, Menon K, Coleman CN: Antiangiogenic agents can increase tumor oxygenation and responses to radiation therapy. Radiat Oncol Invest 2:269-276, 1995
-
(1995)
Radiat Oncol Invest
, vol.2
, pp. 269-276
-
-
Teicher, B.A.1
Dupuis, N.2
Kusomoto, T.3
Robinson, M.F.4
Liu, F.5
Menon, K.6
Coleman, C.N.7
-
8
-
-
0001381632
-
Suppression of tumor metastasis by angiogenesis inhibition
-
Brem H, Ingber D, Blood CH, Bradley D, Urioste S, Folkman J: Suppression of tumor metastasis by angiogenesis inhibition. Surg Forum 42:439-441, 1991
-
(1991)
Surg Forum
, vol.42
, pp. 439-441
-
-
Brem, H.1
Ingber, D.2
Blood, C.H.3
Bradley, D.4
Urioste, S.5
Folkman, J.6
-
9
-
-
0025204095
-
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
-
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamura T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555-557, 1990
-
(1990)
Nature
, vol.348
, pp. 555-557
-
-
Ingber, D.1
Fujita, T.2
Kishimoto, S.3
Sudo, K.4
Kanamura, T.5
Brem, H.6
Folkman, J.7
-
10
-
-
0028013224
-
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
-
Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingber D, Folkman J: Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer 69:212-216, 1994
-
(1994)
Br J Cancer
, vol.69
, pp. 212-216
-
-
Kusaka, M.1
Sudo, K.2
Matsutani, E.3
Kozai, Y.4
Marui, S.5
Fujita, T.6
Ingber, D.7
Folkman, J.8
-
11
-
-
0028329358
-
1 phase of the cell cycle
-
1 phase of the cell cycle. Cancer Res 54:2073-2076, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 2073-2076
-
-
Antoine, N.1
Greimers, R.2
De Roanne, C.3
Kusaka, M.4
Heinen, E.5
Simar, L.J.6
Castronovo, V.7
-
12
-
-
0028344887
-
Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470)
-
Yamamoto T, Sudo K, Fujita T: Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res 14:1-4, 1994
-
(1994)
Anticancer Res
, vol.14
, pp. 1-4
-
-
Yamamoto, T.1
Sudo, K.2
Fujita, T.3
-
13
-
-
0026082066
-
Potent antiangiogenic action of AGM-1470: Comparison to the fumagillin parent
-
Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J: Potent antiangiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174:1070-1976, 1991
-
(1991)
Biochem Biophys Res Commun
, vol.174
, pp. 1070-1976
-
-
Kusaka, M.1
Sudo, K.2
Fujita, T.3
Marui, S.4
Itoh, F.5
Ingber, D.6
Folkman, J.7
-
14
-
-
0027413495
-
Inhibition of angiogenesis and growth of human nerve sheath tumors by AGM-1470
-
Takayamiya Y, Friedlander RM, Brem H, Malick A, Martuza RL: Inhibition of angiogenesis and growth of human nerve sheath tumors by AGM-1470. J Neurosurg 78:470-476, 1993
-
(1993)
J Neurosurg
, vol.78
, pp. 470-476
-
-
Takayamiya, Y.1
Friedlander, R.M.2
Brem, H.3
Malick, A.4
Martuza, R.L.5
-
15
-
-
0027174375
-
Inhibitory effect of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution
-
Yanase T, Tamura M, Fujita K, Kodama S, Tanaka K: Inhibitory effect of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution. Cancer Res 53:2566-2570, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 2566-2570
-
-
Yanase, T.1
Tamura, M.2
Fujita, K.3
Kodama, S.4
Tanaka, K.5
-
16
-
-
0027438574
-
Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearig VX-2 carcinoma by arterial administration of microspheres and oil solution
-
Kamei S, Okada H, Inoue Y, Yoshioka T, Ogawa T, Toguchi H: Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearig VX-2 carcinoma by arterial administration of microspheres and oil solution. J Pharmacol Exper Ther 264(1):469-474, 1993
-
(1993)
J Pharmacol Exper Ther
, vol.264
, Issue.1
, pp. 469-474
-
-
Kamei, S.1
Okada, H.2
Inoue, Y.3
Yoshioka, T.4
Ogawa, T.5
Toguchi, H.6
-
17
-
-
0027853194
-
Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(Chloroacetyl-carbamoyl)fumagillin (TNP-470; AGM-1470)
-
Yamaoka M, Yamamoto T, Masaki T, Ikeyama S, Sudo K, Fujita T: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(Chloroacetyl-carbamoyl)fumagillin (TNP-470; AGM-1470). Cancer Res 53:4262-4267, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 4262-4267
-
-
Yamaoka, M.1
Yamamoto, T.2
Masaki, T.3
Ikeyama, S.4
Sudo, K.5
Fujita, T.6
-
18
-
-
0027257910
-
Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats
-
Toi M, Yamamoto Y, Imazawa T, Takayanagi T, Akutsu K, Tominaga T: Antitumor effect of the angiogenesis inhibitor AGM-1470 and its combination effect with tamoxifen in DMBA induced mammary tumors in rats. Int J Oncol 3:525-528, 1993
-
(1993)
Int J Oncol
, vol.3
, pp. 525-528
-
-
Toi, M.1
Yamamoto, Y.2
Imazawa, T.3
Takayanagi, T.4
Akutsu, K.5
Tominaga, T.6
-
19
-
-
0027487871
-
Angiogenesis inhibitor TNP-470 (AGM-470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines
-
Yamaoka M, Yamamoto T, Ikeyama S, Sudo K, Fujita T: Angiogenesis inhibitor TNP-470 (AGM-470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res 53:5233-5236, 1993
-
(1993)
Cancer Res
, vol.53
, pp. 5233-5236
-
-
Yamaoka, M.1
Yamamoto, T.2
Ikeyama, S.3
Sudo, K.4
Fujita, T.5
-
20
-
-
0027453739
-
The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro
-
Schoof DD, Obando JA, Cusack Jr. JC, Goedegebuure PS, Brem H, Eberlein TJ: The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int J Cancer 55:630-635, 1993
-
(1993)
Int J Cancer
, vol.55
, pp. 630-635
-
-
Schoof, D.D.1
Obando, J.A.2
Cusack Jr., J.C.3
Goedegebuure, P.S.4
Brem, H.5
Eberlein, T.J.6
-
21
-
-
0029042354
-
Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice
-
Tsujimoto H, Hagiwara A, Osaki K, Ohyama T, Sakakibara T, Sakuyama A, Ohgaki M, Imanishi T, Watanabe N, Yamazaki J, Shirasu M, Sakakura C, Shimotsuma M, Takahashi T: Therapeutic effects of the angiogenesis inhibitor TNP-470 against carcinomatous peritonitis in mice. Anti-Cancer Drugs 6:438-442, 1995
-
(1995)
Anti-Cancer Drugs
, vol.6
, pp. 438-442
-
-
Tsujimoto, H.1
Hagiwara, A.2
Osaki, K.3
Ohyama, T.4
Sakakibara, T.5
Sakuyama, A.6
Ohgaki, M.7
Imanishi, T.8
Watanabe, N.9
Yamazaki, J.10
Shirasu, M.11
Sakakura, C.12
Shimotsuma, M.13
Takahashi, T.14
-
22
-
-
0029075356
-
Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes
-
Placidi L, Cretton-Scott E, de Sousa G, Rahmani R, Placidi M, Sommadossi J-P: Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes. Cancer Res 55:3036-3042, 1995
-
(1995)
Cancer Res
, vol.55
, pp. 3036-3042
-
-
Placidi, L.1
Cretton-Scott, E.2
De Sousa, G.3
Rahmani, R.4
Placidi, M.5
Sommadossi, J.-P.6
-
23
-
-
0025924722
-
Angiogenesis inhibition by minocycline
-
Tamargo RJ, Bok RA, Brem H: Angiogenesis inhibition by minocycline. Cancer Res 51:672-675, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 672-675
-
-
Tamargo, R.J.1
Bok, R.A.2
Brem, H.3
-
24
-
-
0004750048
-
Suramin, an inhibitor of angiogenesis, suppresses endothelial cell growth, migration and plasminogen activator activity
-
Takano S, Gately S, Neville M, Herblin WF, Gross JL, Brem S: Suramin, an inhibitor of angiogenesis, suppresses endothelial cell growth, migration and plasminogen activator activity. Proc Amer Assoc Cancer Res 34:74, 1993
-
(1993)
Proc Amer Assoc Cancer Res
, vol.34
, pp. 74
-
-
Takano, S.1
Gately, S.2
Neville, M.3
Herblin, W.F.4
Gross, J.L.5
Brem, S.6
-
25
-
-
0027489946
-
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane
-
Danesi R, Del Bianchi S, Soldani P, Campagni A, La Rocca RV, Myers CE, Paparelli A, Del Tacca M: Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br J Cancer 68:932-938, 1993
-
(1993)
Br J Cancer
, vol.68
, pp. 932-938
-
-
Danesi, R.1
Del Bianchi, S.2
Soldani, P.3
Campagni, A.4
La Rocca, R.V.5
Myers, C.E.6
Paparelli, A.7
Del Tacca, M.8
-
26
-
-
0024593227
-
Suramin: An anticancer drug with a unique mechanism of action
-
Stein CA, La Rocca RV, Thomas R, McAtee N, Myers CE: Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7:499-508, 1989
-
(1989)
J Clin Oncol
, vol.7
, pp. 499-508
-
-
Stein, C.A.1
La Rocca, R.V.2
Thomas, R.3
McAtee, N.4
Myers, C.E.5
-
27
-
-
0025090695
-
Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: Reversal by suramin
-
Yayon A, Klagsbrun M: Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. Proc Nat Acad Sci USA 87:5346-5350, 1990
-
(1990)
Proc Nat Acad Sci USA
, vol.87
, pp. 5346-5350
-
-
Yayon, A.1
Klagsbrun, M.2
-
28
-
-
0028840752
-
Antiproliferative and angiostatic activity of suramin analogues
-
Firsching A, Nickel P, Mora P, Allolio B: Antiproliferative and angiostatic activity of suramin analogues. Cancer Res 55:4957-4961, 1995
-
(1995)
Cancer Res
, vol.55
, pp. 4957-4961
-
-
Firsching, A.1
Nickel, P.2
Mora, P.3
Allolio, B.4
-
29
-
-
0029078689
-
Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables
-
Dawson NA, Cooper MR, Figg WD, Headlee DJ, Thibault A, Bergan RC, Steinberg SM, Sausville EA, Myers CE, Sartor O: Antitumor activity of suramin in hormone-refractory prostate cancer controlling for hydrocortisone treatment and flutamide withdrawal as potentially confounding variables. Cancer 76:453-462, 1995
-
(1995)
Cancer
, vol.76
, pp. 453-462
-
-
Dawson, N.A.1
Cooper, M.R.2
Figg, W.D.3
Headlee, D.J.4
Thibault, A.5
Bergan, R.C.6
Steinberg, S.M.7
Sausville, E.A.8
Myers, C.E.9
Sartor, O.10
-
30
-
-
0028318791
-
Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator
-
Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S: Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 54:2654-2660, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 2654-2660
-
-
Takano, S.1
Gately, S.2
Neville, M.E.3
Herblin, W.F.4
Gross, J.L.5
Engelhard, H.6
Perricone, M.7
Eidsvoog, K.8
Brem, S.9
-
31
-
-
0024986664
-
Soybeans inhibit mammary tumor in models of breast cancer
-
Pariza M, Liss AR (eds), Wiley-Liss. New York
-
Barnes S, Grubbs C, Setchell KDR, Carlson J: Soybeans inhibit mammary tumor in models of breast cancer. In: Pariza M, Liss AR (eds), Mutagens and carcinogens in the diet. Wiley-Liss. New York, 1990, pp 239-253
-
(1990)
Mutagens and Carcinogens in the Diet
, pp. 239-253
-
-
Barnes, S.1
Grubbs, C.2
Setchell, K.D.R.3
Carlson, J.4
-
32
-
-
0025770650
-
The role of soy products in reducing risk of cancer
-
Messina M, Barnes S: The role of soy products in reducing risk of cancer. J Natl Cancer Inst 83:541-546, 1991
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 541-546
-
-
Messina, M.1
Barnes, S.2
-
33
-
-
0027179061
-
Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
-
Wei H, Wei L, Frenkel K, Bowen R, Barnes S: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20:1-12, 1993
-
(1993)
Nutr Cancer
, vol.20
, pp. 1-12
-
-
Wei, H.1
Wei, L.2
Frenkel, K.3
Bowen, R.4
Barnes, S.5
-
34
-
-
0025978569
-
Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor
-
Zwiller J, Sassone-Corsi P, Kakazu K, Boyton AL: Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene 6:219-221, 1991
-
(1991)
Oncogene
, vol.6
, pp. 219-221
-
-
Zwiller, J.1
Sassone-Corsi, P.2
Kakazu, K.3
Boyton, A.L.4
-
35
-
-
0025181752
-
Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity
-
Linassier C, Pierre M, Le Peco J-B, Pierre J: Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 39:187-193, 1990
-
(1990)
Biochem Pharmacol
, vol.39
, pp. 187-193
-
-
Linassier, C.1
Pierre, M.2
Le Peco, J.-B.3
Pierre, J.4
-
36
-
-
0025189757
-
Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol
-
Yamashita Y, Kawada S, Nakano H: Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem Pharmacol 39:737-744, 1990
-
(1990)
Biochem Pharmacol
, vol.39
, pp. 737-744
-
-
Yamashita, Y.1
Kawada, S.2
Nakano, H.3
-
37
-
-
0025363503
-
Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein
-
Constantinou A, Kiguchi K, Huberman E: Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res 50:2618-2624, 1990
-
(1990)
Cancer Res
, vol.50
, pp. 2618-2624
-
-
Constantinou, A.1
Kiguchi, K.2
Huberman, E.3
-
38
-
-
0026048132
-
Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of toposiomerases
-
Kondo K, Watanabe T, Oishi M: Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of toposiomerases. Cancer Res 51:5398-5404, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 5398-5404
-
-
Kondo, K.1
Watanabe, T.2
Oishi, M.3
-
39
-
-
0026035529
-
Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases
-
Watanabe T, Kondo K, Oishi M: Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res 51:764-768, 1991
-
(1991)
Cancer Res
, vol.51
, pp. 764-768
-
-
Watanabe, T.1
Kondo, K.2
Oishi, M.3
-
40
-
-
0026044563
-
Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene
-
Peterson G, Barnes S: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667, 1991
-
(1991)
Biochem Biophys Res Commun
, vol.179
, pp. 661-667
-
-
Peterson, G.1
Barnes, S.2
-
41
-
-
0027337210
-
Genistein induces apoptosis in immature human thymocytes by inhibiting toposiomerase-II
-
McCabe Jr. MJ, Orrenius S: Genistein induces apoptosis in immature human thymocytes by inhibiting toposiomerase-II. Biochem Biophys Res Commun 194(2):944-950, 1993
-
(1993)
Biochem Biophys Res Commun
, vol.194
, Issue.2
, pp. 944-950
-
-
McCabe Jr., M.J.1
Orrenius, S.2
-
42
-
-
0025995324
-
Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors
-
O'Dell TJ, Kandel ER, Grant SGN: Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Lett Nature 353:558-560, 1991
-
(1991)
Lett Nature
, vol.353
, pp. 558-560
-
-
O'Dell, T.J.1
Kandel, E.R.2
Grant, S.G.N.3
-
43
-
-
0027427616
-
Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line
-
Kanatani Y, Kasukabe T, Hozumi M, Motoyoshi K: Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line. Leuk Res 17(10):847-853, 1993
-
(1993)
Leuk Res
, vol.17
, Issue.10
, pp. 847-853
-
-
Kanatani, Y.1
Kasukabe, T.2
Hozumi, M.3
Motoyoshi, K.4
-
44
-
-
0028998285
-
Genistein resistance in human leukaemic CCRF-CEM cells: Selection of a diploid cell line with reduced DNA topoisomerase II βisoform
-
Markovits J, Junqua S, Goldwasser F, Venuat A-M, Luccioni C, Beaumatin J, Saucier J-M, Bernheim A, Jacquemin-Sablon A: Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II βisoform. Biochem Pharmacol 50(2): 177-186, 1995
-
(1995)
Biochem Pharmacol
, vol.50
, Issue.2
, pp. 177-186
-
-
Markovits, J.1
Junqua, S.2
Goldwasser, F.3
Venuat, A.-M.4
Luccioni, C.5
Beaumatin, J.6
Saucier, J.-M.7
Bernheim, A.8
Jacquemin-Sablon, A.9
-
45
-
-
0029123452
-
Plasma pharmacokinetics of genistein in mice
-
Supko JG, Malspeis L: Plasma pharmacokinetics of genistein in mice. Int J Oncol 7:847-854, 1995
-
(1995)
Int J Oncol
, vol.7
, pp. 847-854
-
-
Supko, J.G.1
Malspeis, L.2
-
46
-
-
0027464720
-
Genistein, a dietary-derived inhibitor of in vitro angiogenesis
-
Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Nat Acad Sci USA 90:2690-2694, 1993
-
(1993)
Proc Nat Acad Sci USA
, vol.90
, pp. 2690-2694
-
-
Fotsis, T.1
Pepper, M.2
Adlercreutz, H.3
Fleischmann, G.4
Hase, T.5
Montesano, R.6
Schweigerer, L.7
-
47
-
-
0027043136
-
Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
-
Weidner N, Folkman J, Pozza F, Pierantonio B, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875-1887, 1992
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1875-1887
-
-
Weidner, N.1
Folkman, J.2
Pozza, F.3
Pierantonio, B.4
Allred, E.N.5
Moore, D.H.6
Meli, S.7
Gasparini, G.8
-
48
-
-
0026083903
-
Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
-
Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New Eng J Med 324:1-8, 1991
-
(1991)
New Eng J Med
, vol.324
, pp. 1-8
-
-
Weidner, N.1
Semple, J.P.2
Welch, W.R.3
Folkman, J.4
-
49
-
-
0022964712
-
The characteristic structural feature of the blood vessels of the Lewis lung carcinoma
-
Grunt TW, Lametschwadtner A, Karrer K: The characteristic structural feature of the blood vessels of the Lewis lung carcinoma. Scan Electron Microsc 11:575-589, 1986
-
(1986)
Scan Electron Microsc
, vol.11
, pp. 575-589
-
-
Grunt, T.W.1
Lametschwadtner, A.2
Karrer, K.3
-
50
-
-
0022962804
-
The angioarchitecture of the Lewis lung carcinoma in laboratory mice
-
Grunt TW, Lametschwadtner A, Karrer K, Staindl O: The angioarchitecture of the Lewis lung carcinoma in laboratory mice. Scan Electron Miscrosc 11:557-574, 1986
-
(1986)
Scan Electron Miscrosc
, vol.11
, pp. 557-574
-
-
Grunt, T.W.1
Lametschwadtner, A.2
Karrer, K.3
Staindl, O.4
-
51
-
-
0024517730
-
Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a
-
White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL: Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. Med Intell 18:1197-1200, 1989
-
(1989)
Med Intell
, vol.18
, pp. 1197-1200
-
-
White, C.W.1
Sondheimer, H.M.2
Crouch, E.C.3
Wilson, H.4
Fan, L.L.5
-
52
-
-
0025957251
-
Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a
-
White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A: Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr 118:59-66, 1991
-
(1991)
J Pediatr
, vol.118
, pp. 59-66
-
-
White, C.W.1
Wolf, S.J.2
Korones, D.N.3
Sondheimer, H.M.4
Tosi, M.F.5
Yu, A.6
-
53
-
-
0027482301
-
Expression of basic fibroblast growth factor in primary human renal tumors: Correlation with poor survival
-
Nanus DM, Schmitz-Dräger BJ, Motzer RJ, Lee AC, Vlamis V, Cordon-Cardo C, Albino AP, Reuter VE: Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival. J Natl Cancer Inst 85:1597-1599, 1993
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 1597-1599
-
-
Nanus, D.M.1
Schmitz-Dräger, B.J.2
Motzer, R.J.3
Lee, A.C.4
Vlamis, V.5
Cordon-Cardo, C.6
Albino, A.P.7
Reuter, V.E.8
-
54
-
-
0026651498
-
Molecular determinants of growth, angiogenesis, and metastases in breast cancer
-
Dickson RB, Lippman ME: Molecular determinants of growth, angiogenesis, and metastases in breast cancer. Semin Oncol 19:286-298, 1992
-
(1992)
Semin Oncol
, vol.19
, pp. 286-298
-
-
Dickson, R.B.1
Lippman, M.E.2
-
55
-
-
7344246142
-
Prognostic factors in breast cancer
-
Aaltoma S, Lipponen P: Prognostic factors in breast cancer (review). Int J Oncol 1:153-159, 1992
-
(1992)
Int J Oncol
, vol.1
, pp. 153-159
-
-
Aaltoma, S.1
Lipponen, P.2
-
56
-
-
0027192298
-
Pathobiological characteristics of the first primary and risk of metachronous contralateral invasive breast carcinoma: Clinical implications
-
Gasparini G, Gullick WJ, Bevilacqua P, Pozza F, Lemoine NR, Meli S, Boracchi P, La Malfa G, Weidner N: Pathobiological characteristics of the first primary and risk of metachronous contralateral invasive breast carcinoma: clinical implications. Int J Oncol 2:781-790, 1993
-
(1993)
Int J Oncol
, vol.2
, pp. 781-790
-
-
Gasparini, G.1
Gullick, W.J.2
Bevilacqua, P.3
Pozza, F.4
Lemoine, N.R.5
Meli, S.6
Boracchi, P.7
La Malfa, G.8
Weidner, N.9
-
57
-
-
0027245426
-
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer
-
Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A(8):1141-1145, 1993
-
(1993)
Eur J Cancer
, vol.29 A
, Issue.8
, pp. 1141-1145
-
-
Van Hoef, M.E.H.M.1
Knox, W.F.2
Dhesi, S.S.3
Howell, A.4
Schor, A.M.5
-
58
-
-
0029069833
-
Influence of an anti-angiogenic treatment on 9L gliosarcoma: Oxygenation and response to cytotoxic therapy
-
Teicher BA, Holden SA, Ara G, Dupuis N, Liu F, Yuan J, Ikebe M, Kakeji Y: Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy. Int J Cancer 61(5):732-737, 1995
-
(1995)
Int J Cancer
, vol.61
, Issue.5
, pp. 732-737
-
-
Teicher, B.A.1
Holden, S.A.2
Ara, G.3
Dupuis, N.4
Liu, F.5
Yuan, J.6
Ikebe, M.7
Kakeji, Y.8
|